Oglemilast clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses oglemilast is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2008 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Forest Laboratories (3) · Glenmark Pharmaceuticals Europe Ltd. (R&D) (1)
Studies
Open first, then newest update. How each study uses oglemilast is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Forest LaboratoriesNCT00671073Written as Oglemilast
- Study of Oglemilast for the Prevention of Asthma.CompletedPhase 2Forest LaboratoriesNCT00322283Written as Oglemilast
- Study of Oglemilast for the Treatment of AsthmaCompletedPhase 2Forest LaboratoriesNCT00322686Written as Oglemilast
- A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent AsthmaStatus unknownPhase 2Glenmark Pharmaceuticals Europe Ltd. (R&D)NCT00859404Written as oglemilast
Codes
What other systems call oglemilast · ClinicalTrials.gg INT004849
- MeSH (NLM) C506613oglemilastOne source NLM
- UNII (FDA) 67GXQ6WCC6OGLEMILASTConfirmed FDA, NLM, Wikidata
- Wikidata Q27264129oglemilastConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87376OglemilastOne source FDA
- DrugBank DB12375One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C506613 | oglemilast | One source NLM |
| UNII (FDA) | 67GXQ6WCC6 | OGLEMILAST | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27264129 | oglemilast | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87376 | Oglemilast | One source FDA |
| DrugBank | DB12375 | — | One source Wikidata |
Also registered as oglemilast sodium (UNII 0J3S7PC0H3).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.